Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma [NA]

View source ↗

Summary

A clinical trial update indicates Alpha Tau Medical's DaRT alpha radiation emitter device is being studied for recurrent glioblastoma and recurrent gliomas, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliomas

Drugs mentioned

• DaRT (Diffusing Alpha-emitters Radiation Therapy) Device (diffusing alpha-emitter radiation therapy device)

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Recurrent Glioblastoma, Recurrent Gliomas | NA | Status: RECRUITING